| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 72,462 | 73,290 | 70,711 | 73,470 | | Cost of Revenue | 58,988 | 60,161 | 59,988 | 65,368 | | | Gross Profit | 13,474 | 13,129 | 10,723 | 8,102 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 11,084 | 10,889 | 9,692 | 10,292 | | Non Recurring |
-
|
-
| 6,437 | 3,271 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 2,390 | 2,240 | (5,406) | (5,461) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
| 685 | | Earnings Before Interest And Taxes | 2,174 | 2,240 | (5,406) | (4,776) | | Interest Expense | (178) | 103 | 75 | 726 | | Income Before Tax | 2,352 | 2,137 | (5,481) | (5,502) | | Income Tax Expense | 557 | 810 | (1,493) | (2,361) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 1,795 | 1,327 | (3,988) | (3,141) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| 4,640 |
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,795 | 1,327 | 652 | (3,141) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,795 | $1,327 | $652 | ($3,141) |
|
0.02% Nasdaq 0.00%
Income Statement
